GLP-1 receptors being widely available in the different organs and tissues such as the brain, lung, pancreas, stomach, heart, and endometrium has explained the broader therapeutic application of GLP-1RA
Typical use levels vary from 0.3-1% as a preservative booster and go up to 2% to condition skin
Strategies to reduce nausea include: (1) dose fractionation (split a 2 mg dose into 0.5 mg every 2 hours), (2) administering with food, (3) gradual dose escalation (start at 0.25 mg and increase by 0.25 mg every 3 days), and (4) co-administration of antiemetics (in research contexts)
Monitoring your symptoms and maintaining open communication with your healthcare provider are also crucial
Reconstituted peptides are typically more susceptible to deterioration and contamination over time than lyophilized peptides
Insurance Experience Timeline: While slower, insurance-based care often provides more thorough evaluation and integration with existing healthcare